Safety Study of an Oral Vitamin D Analog in Postmenopausal Women

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

June 30, 2004

Conditions
Postmenopausal Osteoporosis, Multiple Sites
Interventions
DRUG

2MD

DRUG

Calcitriol

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Deltanoid Pharmaceuticals

INDUSTRY

NCT01969656 - Safety Study of an Oral Vitamin D Analog in Postmenopausal Women | Biotech Hunter | Biotech Hunter